Join to View Full Profile
7979 Wurzbach RdSan Antonio, TX 78229
Phone+1 210-450-1143
Fax+1 210-450-0407
Dr. Mahadevan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
(King's College London - School of Medicine)Class of 1990, MD- Birkbeck College University of LondonPh.D., Protein Crystallography, 1982 - 1986
- University of ReadingB.Sc., Physiology and Biochemistry with Chemistry, Honors, 1979 - 1982
University of ConnecticutResidency, Internal Medicine
National Institutes of Health Clinical CenterFellowship, Medical Oncology
Certifications & Licensure
TX State Medical License 2020 - 2027
AZ State Medical License 2002 - 2021
TN State Medical License 2012 - 2017
MS State Medical License 2013 - 2016
CT State Medical License 1998 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Dane Foundation Fellowship British Medical Council
- National Academy of Inventors Senior Member National Academy of Inventors, 2019
- Resistance mechanisms in HER2+ breast Cancer Flinn Foundation Award, 2017-2019
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastat...Breelyn A Wilky, Gary K Schwartz, Michael S Gordon, Anthony B El-Khoueiry, Andrea J Bullock
Journal of Clinical Oncology. 2025-04-10 - A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma.Baskaran Subramani, Patrick J Conway, Aisha Al-Khinji, Kun Zhang, Ritu Pandey
Cancers. 2024-12-21 - 18 citationsBotensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, Apostolia M Tsimberidou, Joseph E Grossman
Nature Medicine. 2024-09-01
Professional Memberships
- Member
- Member
- Member
- Southwest Oncology Group (SWOG)Member
- Early Therapeutic Committee (Liaison) – SWOG Lymphoma CommitteeMember
- Memphis Medical SocietyMember
- Molecular Cancer Therapeutics – Editorial BoardMember
- Astex Therapeutics – Scientific AdvisorMember
- SuperGen Pharmaceuticals, Inc. – Scientific AdvisorMember
- Current Medicinal Chemistry – Editorial board (Anti-cancer Drug Design)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
